Home » Topics » Regulatory

Regulatory
RSS

Effexor XR approved for adults with panic disorder

Nov. 22, 2005

BioMimetic's GEM-21S approved for periodontal bone defects

Nov. 22, 2005

Shanghai Sunway Biotech's H101 approved for refractory nasopharyngeal cancer

Nov. 18, 2005

Procoralan receives European approval for chronic stable angina

Nov. 16, 2005

FDA approves new indication for Invanz

Nov. 16, 2005

FDA approves intravenous administration of Oncaspar

Nov. 14, 2005

Tarceva approved in combination with gemcitabine for pancreatic cancer

Nov. 3, 2005

First worldwide approval for Exjade in U.S.

Nov. 3, 2005

Noxafil approved in E.U. for invasive fungal infections

Oct. 28, 2005

Ebixa receives European approval for moderate Alzheimer's disease

Oct. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...